Bausch Health Companies | VRX - Gewinn Vor Steuern

Aktienkurs
7.42
Täglich Wechseln
0.09 1.16%
Monatlich
-6.02%
Jährlich
13.90%
Q2 Prognose
7.72




Gewinn Vor Steuern Veränderung Datum
Amgen USD 1.51B 2.41B 2025-12
ANI Pharmaceuticals USD 31.48M 18.04M 2025-12
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Bausch Health Companies USD 56M 162M 2025-12
Biogen USD 377.7M 433.7M 2026-03
Bristol-Myers Squibb USD 1.47B 1.64B 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 9.91M 5.33M 2025-12
Danaher USD 1.24B 138M 2026-03
Drreddys Laboratories INR 15.43B 1.96B 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Gilead Sciences USD 2.08B 1.56B 2025-12
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novo Nordisk DKK 33.8B 3.23B 2025-06
Pacira USD 571K 8.95M 2025-12
Perrigo USD -1.33B 1.35B 2025-12
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 61.81M 7.32M 2025-12
Supernus Pharmaceuticals USD -5.95M 4.04M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Zoetis USD 761M 126M 2025-12